Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactoferrin in Heart Failure with Iron Deficiency
NCT06427200Phase 4Not yet recruiting
- Sponsor
- Cairo University
- Start
- Jul 2024
- Primary completion
- Jul 2027
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised trial of lactoferrin in heart failure with reduced ejection fraction (HFrEF) (3 arms), sponsored by Cairo University. Primary endpoint: Health-Related Quality of Life at 3 months. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
lactoferrin
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT06427200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06427200.